Floatz logo

in1011-n17 hcl

Post Herpetic Neuralgia

iN Therapeutics Co., Ltd.Phase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the Post Herpetic Neuralgia cohort.

Asset / SponsorPhaseRating
LIDOCAINE
Seoul National University Hospital
Phase 4BBB
Capsaicin
Astellas Pharma Europe Ltd.
Phase 4BBB
Pregabalin
Neurodawn Pharmaceutical Co., Ltd.
Phase 4BBB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
University of Medicine and Pharmacy at Ho Chi Minh City
Phase 4BBB
Capsaicin
Astellas Pharma Europe Ltd.
Phase 4BBB

View all 50 →

Same molecule, other indications

in1011-n17 hcl is also rated in:

osteoarthritisDormant
CC
Indicative ·
43 / 100
View asset →
Dorsal Root GanglionDormant
CC
Indicative ·
43 / 100
View asset →
Nav 1.7Dormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →